Aortic stenosis trials in Canada
21 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
- Where
- Montreal
- Age
- 18 years and over
- People
- 2,130
- Run by
- McGill University Health Centre/Research Institute of the McGill University Health Centre
See details and how to joinNCT04464655 - No phaseTaking peopleValve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.
- Where
- Québec
- Age
- 18 years to 80 years
- People
- 150
- Run by
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
See details and how to joinNCT06420830 - No phaseTaking peopleSystematic Ambulatory ECG Monitoring Following TAVI
- Where
- Québec
- Age
- 18 years and over
- People
- 754
- Run by
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
See details and how to joinNCT07739316 - Phase 4Not yet taking people in CanadaApplication of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study)
- Where
- Edmonton
- Age
- 18 years and over
- People
- 600
- Run by
- University of Alberta
See details and how to joinNCT06818006 - No phaseTaking peopleClinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
- Where
- Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Saint John, Sherbrooke
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Montreal Heart Institute
See details and how to joinNCT03303612 - No phaseTaking peopleALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
- Where
- Hamilton, Québec, Vancouver
- People
- 200 worldwide
- Run by
- Edwards Lifesciences
See details and how to joinNCT05172973 - No phaseTaking peopleALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
- Where
- Hamilton, Québec, Vancouver
- People
- 1,234 worldwide
- Run by
- Edwards Lifesciences
See details and how to joinNCT05172960 - No phaseEnrolling by invitationENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
- Where
- Montreal, Ottawa, Saint John, Toronto, Vancouver
- Age
- 18 years and over
- People
- 1,500 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT05932615 - No phaseNot yet taking people in CanadaSame-Day Versus Standard Hospital Discharge After TAVI (HOME-TAVI)
- Where
- Québec
- Age
- 18 years and over
- People
- 764 worldwide
- Run by
- Hospital Clinic of Barcelona
See details and how to joinNCT07738575 - No phaseTaking peopleA Study of Transcatheter Aortic Valve Replacement Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm
- Where
- Calgary, Halifax, Hamilton, Newmarket, Ottawa, Québec, Toronto
- People
- 290 worldwide
- Run by
- World Health Research Inc.
See details and how to joinNCT06991517 - Phase 2/3Taking peopleAtaciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
- Where
- Montreal, Québec, Winnipeg
- Age
- 50 years and over
- People
- 1,276 worldwide
- Run by
- Kardigan, Inc.
See details and how to joinNCT07001800 · EU 2025-522176-86-01 - Phase 2Taking peopleA Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- Where
- Cambridge, Montreal, North York, Ottawa, Québec
- Age
- 50 years to 80 years
- People
- 502 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05646381 · EU 2022-502135-19-00 - No phaseTaking peopleMiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
- Where
- Toronto
- Age
- 18 years to 85 years
- People
- 1,300 worldwide
- Run by
- Aristotle University Of Thessaloniki
See details and how to joinNCT05487612 - No phaseTaking peopleValve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
- Where
- Québec
- Age
- 18 years and over
- People
- 310 worldwide
- Run by
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
See details and how to joinNCT05459233 - No phaseTaking peoplePROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- Where
- Hamilton, Vancouver
- Age
- 65 years and over
- People
- 2,250 worldwide
- Run by
- Edwards Lifesciences
See details and how to joinNCT04889872 - No phaseTaking peopleStaged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Where
- Edmonton, Halifax, Hamilton, Montreal, New Westminster, Ottawa, Regina, Saint John, Sherbrooke, Toronto, Vancouver, Winnipeg
- People
- 4,000 worldwide
- Run by
- University of British Columbia
See details and how to joinNCT04634240 - No phaseTaking peopleEffect of Fetal Aortic Valvuloplasty on Outcomes
- Where
- Toronto
- Age
- 23 weeks to 31 weeks
- People
- 200 worldwide
- Run by
- Queen Silvia Children's Hospital, Gothenburg, Sweden
See details and how to joinNCT05386173 - Phase 4Taking peopleAngiotensin Receptor Blockers in Aortic Stenosis
- Where
- Québec
- Age
- 20 years to 99 years
- People
- 144 worldwide
- Run by
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
See details and how to joinNCT04913870 · EU 2024-518389-28-00 - No phaseTaking peopleThe Role of Cardiac Mechanics, Biomarkers and Frailty in Aortic Stenosis
- Where
- Montreal
- Age
- 18 years and over
- People
- 450
- Run by
- Christine Henri
See details and how to joinNCT02856620 - No phaseTaking peopleTranslational-Omics in Aortic Stenosis (TOmAS) Biobank
- Where
- Montreal
- Age
- 19 years and over
- People
- 10,000
- Run by
- McGill University Health Centre/Research Institute of the McGill University Health Centre
See details and how to joinNCT05930899 - No phaseTaking peoplePARTNER 3 Trial - Aortic Valve-in-Valve
- Where
- Vancouver
- People
- 125 worldwide
- Run by
- Edwards Lifesciences
See details and how to joinNCT03003299